PMN
Price
$1.12
Change
+$0.68 (+154.55%)
Updated
Jul 21 closing price
Capitalization
36.61M
27 days until earnings call
VANI
Price
$1.55
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
91.83M
28 days until earnings call
Interact to see
Advertisement

PMN vs VANI

Header iconPMN vs VANI Comparison
Open Charts PMN vs VANIBanner chart's image
ProMIS Neurosciences
Price$1.12
Change+$0.68 (+154.55%)
Volume$290.4M
Capitalization36.61M
Vivani Medical
Price$1.55
Change-$0.00 (-0.00%)
Volume$64.83K
Capitalization91.83M
PMN vs VANI Comparison Chart in %
Loading...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PMN vs. VANI commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMN is a Buy and VANI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (PMN: $1.12 vs. VANI: $1.55)
Brand notoriety: PMN and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMN: 3153% vs. VANI: 52%
Market capitalization -- PMN: $36.61M vs. VANI: $91.83M
PMN [@Biotechnology] is valued at $36.61M. VANI’s [@Biotechnology] market capitalization is $91.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMN’s FA Score shows that 0 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • PMN’s FA Score: 0 green, 5 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, VANI is a better buy in the long-term than PMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMN’s TA Score shows that 6 TA indicator(s) are bullish while VANI’s TA Score has 5 bullish TA indicator(s).

  • PMN’s TA Score: 6 bullish, 4 bearish.
  • VANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PMN is a better buy in the short-term than VANI.

Price Growth

PMN (@Biotechnology) experienced а +115.38% price change this week, while VANI (@Biotechnology) price change was +4.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

PMN is expected to report earnings on Aug 18, 2025.

VANI is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($91.8M) has a higher market cap than PMN($36.6M). VANI YTD gains are higher at: 33.621 vs. PMN (18.168). PMN has higher annual earnings (EBITDA): -933.94K vs. VANI (-24.6M). VANI has more cash in the bank: 13M vs. PMN (8.4M). PMN has less debt than VANI: PMN (4.05M) vs VANI (18.9M). PMN (0) and VANI (0) have equivalent revenues.
PMNVANIPMN / VANI
Capitalization36.6M91.8M40%
EBITDA-933.94K-24.6M4%
Gain YTD18.16833.62154%
P/E Ratio12.44N/A-
Revenue00-
Total Cash8.4M13M65%
Total Debt4.05M18.9M21%
FUNDAMENTALS RATINGS
PMN vs VANI: Fundamental Ratings
PMN
VANI
OUTLOOK RATING
1..100
5029
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
9338
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VANI's Valuation (57) in the null industry is somewhat better than the same rating for PMN (94). This means that VANI’s stock grew somewhat faster than PMN’s over the last 12 months.

VANI's Profit vs Risk Rating (100) in the null industry is in the same range as PMN (100). This means that VANI’s stock grew similarly to PMN’s over the last 12 months.

PMN's SMR Rating (94) in the null industry is in the same range as VANI (100). This means that PMN’s stock grew similarly to VANI’s over the last 12 months.

VANI's Price Growth Rating (38) in the null industry is somewhat better than the same rating for PMN (93). This means that VANI’s stock grew somewhat faster than PMN’s over the last 12 months.

PMN's P/E Growth Rating (99) in the null industry is in the same range as VANI (100). This means that PMN’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PMNVANI
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
77%
Momentum
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI9.130.44
+5.06%
Ultralife Corp
BMRA3.500.10
+2.94%
Biomerica
ARE78.270.10
+0.13%
Alexandria Real Estate Equities
SKT31.53-0.01
-0.03%
Tanger
IMTX5.85-0.15
-2.50%
Immatics NV

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with BBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
+154.49%
BBIO - PMN
40%
Loosely correlated
-1.31%
ABOS - PMN
29%
Poorly correlated
+3.33%
GALT - PMN
25%
Poorly correlated
-2.14%
VANI - PMN
25%
Poorly correlated
N/A
NBY - PMN
25%
Poorly correlated
-1.58%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
59%
Loosely correlated
N/A
ENVB - VANI
41%
Loosely correlated
+3.79%
GLSI - VANI
34%
Loosely correlated
+1.47%
KYTX - VANI
32%
Poorly correlated
-0.77%
GBIO - VANI
32%
Poorly correlated
+3.62%
More